Camarda Financial Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-18
Closed -$2K 280
2016
Q4
$2K Buy
+18
New +$2K ﹤0.01% 232
2015
Q2
Sell
-340
Closed -$39K 292
2015
Q1
$39K Buy
340
+106
+45% +$12.7K 0.02% 149
2014
Q4
$26K Sell
234
-390
-63% -$41.1K 0.02% 177
2014
Q3
$59K Buy
624
+214
+52% +$19.3K 0.04% 111
2014
Q2
$35K Buy
+410
New +$31.2K 0.02% 147
2014
Q1
Sell
-766
Closed -$65K 245
2013
Q4
$65K Buy
+766
New +$60.6K 0.05% 95

Other funds holding CELG

Camarda Financial Advisors's CELG Position: Q1 2017 in Review

Camarda Financial Advisors sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 18 shares — an estimated $2K sold.

Camarda Financial Advisors first reported a position in CELG in Q4 2013 and held it in 6 quarters. The position peaked at $65K in Q4 2013. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • Camarda Financial Advisors reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
  • Camarda Financial Advisors sold 18 Celgene Corp shares in Q1 2017, an estimated $2K.
  • Camarda Financial Advisors first reported a position in Celgene Corp in Q4 2013 and held it in 6 quarters.
  • Camarda Financial Advisors's Celgene Corp position peaked at $65K in Q4 2013.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Camarda Financial Advisors's 13F filing for Q1 2017, filed 5 May 2017.